ST Elevation Myocardial Infarction Clinical Trial
Official title:
Correlation of QT Dispersion With Myocardial Perfusion in Patients With ST Elevation Myocardial Infarction Treated by Primary Per Cutaneous Coronary Intervention
To correlate QT dispersion on 12-lead surface ECG with myocardial reperfusion evaluated by myocardial blush grade and Thrombolysis in myocardial infarction (TIMI) flow grades in patients with ST elevation myocardial infarction treated by Primary Per cutaneous coronary intervention
Worldwide, coronary artery disease (CAD) is the most frequent cause of death. Over seven
million people every year die from CAD, accounting for 12.8% of all deaths. Every sixth man
and every seventh woman in Europe die from myocardial infarction. The in-hospital mortality
of STEMI patients in the national registries of the European society of cardiology (ESC)
countries varies between 6% and 14%.
ST elevation myocardial infarction (STEMI) generally results from intraluminal thrombus
formation and occlusion of a ruptured or an unstable plaque .
The main goal of therapy in STEMI is to restore microvascular flow and sustain the myocardial
perfusion .
Reperfusion therapy for acute myocardial infarction (AMI) is aimed at achieving prompt
restoration of myocardial perfusion to maximize preservation of the electrical and mechanical
integrity of the jeopardized myocardium. Percutaneous coronary intervention (PCI) has
increased the rate of successful recanalization of infarct-related arteries (IRAs) to >90% .
A variety of markers including ECG and coronary angiography have been utilized to assess
myocardial reperfusion .
The prolongation of QRS duration,evaluated by a standard 12-lead ECG, is a marker of
ventricular dysfunction and has been associated with a poor prognosis in STEMI .
QT-interval parameters are potentially proposed as available non-invasive markers for
assessing the ventricular homogeneity as well as for predicting electrical instability ,QT
interval (QTI) is defined as the longest interval from the beginning of the QRS complex to
the end of the T-wave; QT dispersion (QTd) is defined as the difference between the longest
and shortest QTI, and reflects electrical activity of the ventricles . .
The prolongation of the latter parameter is a main predictor for fatal arrhythmia in patients
with myocardial infarction (MI) .
The measurement of QTI and QTd parameters are dependent on heart rate and can be corrected by
the QT correction formulas, which are termed the corrected QTI (QTc) and QTd (QTcd) .
Myocardial blush grade (MBG) is validated measurement of myocardial perfusion . The MBG is
used to assess the washout of myocardial blush during angiography. Grade 0 is defined as the
failure of the contrast to enter the microvasculature. In grade 1 cases, contrast enters
slowly, but fails to exit the microvasculature. Grade 2 defines delayed entry and exit from
the microvasculature. Finally, grade 3 indicates normal entry and exit from the
microvasculature .
ECG is a necessary, simple, rapid and non invasive tool for the diagnosis of myocardial
infarction and evaluation of myocardial reperfusion that still to be investigated . QT
dispersion is a crude and approximate measure of a general abnormality of repolarization; it
reflects inhomogeneity of ventricular repolarization . This measurement is an attempt to
distinguish between myocardium that is homogeneous from myocardium that displays
inhomogeneity, which is accompanied by increased dispersion of the ventricular recovery times
and prolongation of repolarization
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05601999 -
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
|
Phase 3 | |
| Recruiting |
NCT06147986 -
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
|
Phase 2 | |
| Not yet recruiting |
NCT05881382 -
Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
|
Phase 3 | |
| Enrolling by invitation |
NCT02615015 -
SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls
|
N/A | |
| Recruiting |
NCT05812963 -
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute STEMI
|
N/A | |
| Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
| Recruiting |
NCT05450757 -
Shanghai ST-segment Elevation Myocardial Infarction Cohort
|
||
| Active, not recruiting |
NCT03278509 -
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
|
Phase 4 | |
| Not yet recruiting |
NCT03263468 -
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
|
N/A | |
| Completed |
NCT03156699 -
The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction
|
||
| Not yet recruiting |
NCT03266328 -
Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University
|
N/A | |
| Enrolling by invitation |
NCT04970238 -
Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction
|
Phase 4 | |
| Recruiting |
NCT02557217 -
NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
|
Phase 2 | |
| Recruiting |
NCT02224534 -
Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
|
Phase 4 | |
| Completed |
NCT01136187 -
Trial Comparing Radial and Femoral Approach in Primary Percutaneous Coronary Intervention (PCI)
|
N/A | |
| Not yet recruiting |
NCT04068116 -
Impact of Ischemic Post-conditioning
|
N/A | |
| Not yet recruiting |
NCT04063345 -
Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT03646357 -
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
|
Phase 4 | |
| Completed |
NCT03984071 -
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
|
||
| Completed |
NCT03740776 -
The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI
|